SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · XYL

Xylem Reports Third Quarter 2026 Results and Announces

Xylem Inc. · Filed · SEC Form 8-K, Item 2.02

Xylem Inc. company page Original on SEC.gov ↗

Revenue $2.2 billion −3% vs a year ago
EPS $1.25 +34% vs a year ago
Guidance issuedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue decreased 3% year on year to $2.2 billion, while EPS climbed 34% to $1.25. Earnings growing while sales shrink can reflect cost control or buybacks rather than stronger demand, so the margin detail in the original release matters. The company issued new guidance, which gives a first marker for expectations in the periods ahead.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$2.2 billion −3% vs a year ago

…Revenue of $2.2 billion, down 3% on a reported basis and flat organically…
EPS

$1.25 +34% vs a year ago

…Earnings per share of $1.25, up 34%; $1.44 on an adjusted basis, up 5%.…
Guidance

Guidance issued

…Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items | Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the i…

Read the original press release on SEC.gov ↗ Filing index ↗

Trend: last 1 reports

All releases →

Revenue growth (YoY)

EPS growth (YoY)

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.